How much profit has PhenomeX made this year?
PhenomeX has made -59.16 M USD this year.
PhenomeX Net Income 2024
PhenomeX Net Income
-59.16 M USD
Ticker
CELL
ISIN
US0843101017
WKN
A2P9RR
In 2024, PhenomeX's profit amounted to -59.16 M USD, a -49.04% increase from the -116.1 M USD profit recorded in the previous year.
The PhenomeX Net Income history
| YEAR | NET INCOME (undefined USD) |
|---|---|
| 2026e | - |
| 2025e | - |
| 2024e | - |
| 2023e | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
PhenomeX Revenue, EBIT, Net Income US0843101017 · A2P9RR
3 years
5 years
10 years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into PhenomeX, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by PhenomeX from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects PhenomeX’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of PhenomeX. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into PhenomeX’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing PhenomeX’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on PhenomeX’s growth potential.
PhenomeX Revenue, EBIT and net profit per share
| Date | PhenomeX Revenue | PhenomeX EBIT | PhenomeX Net Income |
|---|---|---|---|
| 2026e | 182.58 M undefined | 0 undefined | -27.26 M undefined |
| 2025e | 135.93 M undefined | -44.17 M undefined | -28.07 M undefined |
| 2024e | 104.06 M undefined | -53.08 M undefined | -59.16 M undefined |
| 2023e | 78.03 M undefined | -91.21 M undefined | -116.1 M undefined |
| 2022 | 78.6 M undefined | -94.54 M undefined | -98.04 M undefined |
| 2021 | 85.39 M undefined | -70.79 M undefined | -71.72 M undefined |
| 2020 | 64.3 M undefined | -40.39 M undefined | -43.32 M undefined |
| 2019 | 56.69 M undefined | -16.54 M undefined | -21.5 M undefined |
| 2018 | 31.3 M undefined | -21.16 M undefined | -26.54 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2018 | 31.3 M USD | -21.16 M USD | -26.54 M USD |
| 2019 | 56.69 M USD | -16.54 M USD | -21.5 M USD |
| 2020 | 64.3 M USD | -40.39 M USD | -43.32 M USD |
| 2021 | 85.39 M USD | -70.79 M USD | -71.72 M USD |
| 2022 | 78.6 M USD | -94.54 M USD | -98.04 M USD |
| 2023e | 78.03 M USD | -91.21 M USD | -116.1 M USD |
| 2024e | 104.06 M USD | -53.08 M USD | -59.16 M USD |
| 2025e | 135.93 M USD | -44.17 M USD | -28.07 M USD |
| 2026e | 182.58 M USD | 0 USD | -27.26 M USD |
PhenomeX stock margins US0843101017 · A2P9RR
The PhenomeX margin analysis displays the gross margin, EBIT margin, as well as the profit margin of PhenomeX. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for PhenomeX.
3 years
5 years
10 years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the PhenomeX's sales revenue. A higher gross margin percentage indicates that the PhenomeX retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the PhenomeX's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the PhenomeX's total revenue generated. When comparing the revenue margin year over year, investors can gauge the PhenomeX's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the PhenomeX. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the PhenomeX's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
PhenomeX Margin History
| PhenomeX Gross margin | PhenomeX Profit margin | PhenomeX EBIT margin | PhenomeX Profit margin |
|---|---|---|---|
| 2026e | 68.42 % | 0 % | -14.93 % |
| 2025e | 68.42 % | -32.49 % | -20.65 % |
| 2024e | 68.42 % | -51.01 % | -56.85 % |
| 2023e | 68.42 % | -116.9 % | -148.8 % |
| 2022 | 68.42 % | -120.28 % | -124.73 % |
| 2021 | 66.23 % | -82.9 % | -83.99 % |
| 2020 | 69.3 % | -62.81 % | -67.37 % |
| 2019 | 76.7 % | -29.18 % | -37.93 % |
| 2018 | 73.87 % | -67.6 % | -84.79 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2018 | 73.87 % | -67.6 % | -84.79 % |
| 2019 | 76.7 % | -29.18 % | -37.93 % |
| 2020 | 69.3 % | -62.81 % | -67.37 % |
| 2021 | 66.23 % | -82.9 % | -83.99 % |
| 2022 | 68.42 % | -120.28 % | -124.73 % |
| 2023e | 68.42 % | -116.9 % | -148.8 % |
| 2024e | 68.42 % | -51.01 % | -56.85 % |
| 2025e | 68.42 % | -32.49 % | -20.65 % |
| 2026e | 68.42 % | 0 % | -14.93 % |
PhenomeX Aktienanalyse
What does PhenomeX do?
The company Berkeley Lights Inc. (BLI) is a biotech startup that was founded in 2011 by Eric Hobbs and Igor Khandros in California. They both had experience in the semiconductor electronics field and decided to utilize their skills to develop a new technology that allows researchers to quickly and efficiently investigate cell-specific processes. The concept behind BLI is based on a novel technology called the "Beacon system." Cells are held on thousands of tiny microchips and can be selectively manipulated using beams of light. The Beacon system enables researchers to isolate, analyze, and select cells rapidly and efficiently, significantly speeding up and simplifying the research process. BLI's business model can be described as B2B, as the company sells its technology and services to other companies in the biotech industry. BLI has two different divisions in which it utilizes its technology and expertise: the "OptoSelect" program and the "Beacon Discovery" program. BLI's OptoSelect program offers customers the ability to select precise and specific cell lines from a large array of cultures. BLI utilizes its Beacon technology to quickly and efficiently isolate and select cells, saving valuable time and resources for researchers. These cell lines can then be used in the development of drugs and therapies, increasing the chances of successful market introduction. BLI's Beacon Discovery program is focused on accelerating the discovery process of new drugs and therapies. BLI works closely with its customers to expedite the drug development process. By using the Beacon technology, it is possible to identify and test potential drug candidates more quickly, significantly reducing the development time. BLI also offers a range of products based on the Beacon technology. These include devices such as the Lightning™ Digital Array, a system for multi-omics analysis of gene expression, immune response, and cell cycle; the Beacon® Controller, a system for controlling the Beacon® microchip platform; and the Beacon® Pak for consumables. Since its founding, BLI has conducted multiple funding rounds and raised over $180 million for the development of its technology and services. The company has established strong partnerships with leading companies in the biotech industry and collaborates closely with researchers and universities to advance its technology. Overall, BLI has established itself as a leading provider of biotech technologies. Through the use of its Beacon technology, the company has accelerated and simplified the process of cell analysis and selection, speeding up the development of new drugs and therapies and increasing the chances of successful market introduction. With its state-of-the-art products and services, BLI is well-positioned to continue playing a significant role in the biotech industry in the future. PhenomeX ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding PhenomeX's Profit Margins
The profit margins of PhenomeX represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of PhenomeX's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating PhenomeX's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
PhenomeX's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When PhenomeX’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about PhenomeX stock
How has the profit developed compared to last year?
The profit has increased by -49.04% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does PhenomeX publish its earnings?
PhenomeX publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of PhenomeX?
The profits of PhenomeX are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of PhenomeX?
You can learn more about the earnings of PhenomeX by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does PhenomeX pay?
Over the past 12 months, PhenomeX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PhenomeX is expected to pay a dividend of 0 USD.
What is the dividend yield of PhenomeX?
The current dividend yield of PhenomeX is .
When does PhenomeX pay dividends?
PhenomeX pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of PhenomeX?
PhenomeX paid dividends every year for the past 0 years.
What is the dividend of PhenomeX?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is PhenomeX located?
PhenomeX is assigned to the 'Health' sector.
Wann musste ich die Aktien von PhenomeX kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of PhenomeX from 7/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/5/2024.
When did PhenomeX pay the last dividend?
The last dividend was paid out on 7/5/2024.
What was the dividend of PhenomeX in the year 2023?
In the year 2023, PhenomeX distributed 0 USD as dividends.
In which currency does PhenomeX pay out the dividend?
The dividends of PhenomeX are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von PhenomeX
Our stock analysis for PhenomeX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PhenomeX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.